Eli Lilly and Co. announced Wednesday that it will open a new Lilly Gateway Labs site in Philadelphia. The move offers another strong boost to the region’s growing life sciences ecosystem. Lilly will take 44,000 square feet at 2300 Market Street, a Center City life sciences building developed by Breakthrough Properties. The news follows the… Read more »
The life sciences sector has experienced a challenging 2025, marked by federal policy shifts under the Trump administration, including proposed cuts to National Institutes of Health funding, withdrawal of government backing for mRNA vaccine initiatives, new tariffs, and drug pricing reforms. Philadelphia’s biotech ecosystem has felt the impact. Nearly 1,000 local life sciences jobs have… Read more »
Eli Lilly and Co. is reportedly exploring Philadelphia as a potential site for one of its Lilly Gateway Labs biotech incubators, according to industry sources. The Gateway Labs concept serves as an innovation hub offering shared lab and office space for early-stage biotech companies driven by “scientific curiosity.” These incubators focus on advancing research in… Read more »
Orchestra Life Sciences, a consulting firm serving pharmaceutical and biotechnology companies developing therapies for cancer and rare diseases, has officially relocated its global headquarters from Montreal, Canada, to the Philadelphia Navy Yard. The company has leased 7,000 square feet at 1200 Intrepid Avenue, launching with four employees and plans to expand to 20 local staff… Read more »
Even with nearly one million square feet of newly developed lab space currently unoccupied in and around University City, John Grady views the vacancy as evidence of the region’s significant growth in the life sciences sector. Grady, Senior Vice President at Wexford Science & Technology, has recently been named chair of the University City District… Read more »
Following Dispatch Bio’s recent $216 million capital raise, Brandywine Realty Trust CEO Jerry Sweeney expressed optimism about the region’s life sciences sector, calling it in “recovery mode.” “Green shoots on the capital raising front are emerging,” Sweeney noted, pointing to the funding as a positive indicator amid a challenging market. The milestone is notable given… Read more »
The City of Philadelphia is negotiating to establish the police department’s new forensics lab at University Place 3.0, sources say. The eight-story, 250,000-square-foot life sciences building at 4101 Market St., completed in mid-2023, has remained mostly vacant. Currently, Fulton Bank operates a branch on the ground floor, and a Southern seafood fusion restaurant is planned…. Read more »
Legend Biotech Corp., a North Jersey company, is building a 31,000-square-foot R&D center at 2300 Market St. in Philadelphia. The center will occupy the third floor of Breakthrough Properties’ eight-story, 223,000-square-foot life sciences building, set for completion in early 2025. With over 1,200 employees nationwide, Legend Biotech expects the new Center City location to eventually… Read more »
As Hankin Group welcomes tenants to its new 113,000-square-foot life sciences building, the developer is already planning its next lab facility within the expansive Eagleview master-planned development in Exton. This fall, Hankin Group is set to break ground on a 63,000-square-foot life sciences building at 100 Arrowhead Drive. Named ‘Arrowhead,’ the new project comes in… Read more »
Wolf Commercial Real Estate, the leading commercial real estate and advisory firm in South Jersey has been appointed the exclusive listing agent for 2315-2319 North Broad Street, Philadelphia, PA 19132. The Philadelphia property is available for sale. The property holds +/- 12,789 square feet on .33 acres, that could be utilized by opportunity zones and… Read more »
